共 8 条
- [5] Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control[J] . Allan C. Skanes,Jeff S. Healey,John A. Cairns,Paul Dorian,Anne M. Gillis,M. Sean McMurtry,L. Brent Mitchell,Atul Verma,Stanley Nattel. Canadian Journal of Cardiology . 2012 (2)
- [6] Antithrombotic and Thrombolytic Therapy for Valvular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J] . Richard P. Whitlock,Jack C. Sun,Stephen E. Fremes,Fraser D. Rubens,Kevin H. Teoh. Chest . 2012 (2)
- [7] Antithrombotic Therapy for Atrial Fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J] . John J. You,Daniel E. Singer,Patricia A. Howard,Deirdre A. Lane,Mark H. Eckman,Margaret C. Fang,Elaine M. Hylek,Sam Schulman,Alan S. Go,Michael Hughes,Frederick A. Spencer,Warren J. Manning,Jonathan L. Halperin,Gregory Y.H. Lip. Chest . 2012 (2)
- [8] Rivaroxaban versus warfarin in nonvalvular atrial fibrillation .2 M.R. Patel,K.W. Mahaffey,J. Garg,G. Pan,D.E. Singer,W. Hacke,G. Breithardt,J.L. Halperin,G.J. Hankey,J.P. Piccini,R.C. Becker,C.C. Nessel,J.F. Paolini,S.D. Berkowitz,K.A. Fox,R.M. Califf. N Engl J Med . 2011